Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urticaria | 3 | 2022 | 151 | 1.390 |
Why?
|
| Nevus, Pigmented | 2 | 2024 | 222 | 0.950 |
Why?
|
| Carcinoma, Skin Appendage | 1 | 2022 | 5 | 0.840 |
Why?
|
| Adenoma, Sweat Gland | 1 | 2022 | 16 | 0.830 |
Why?
|
| Acrospiroma | 1 | 2022 | 10 | 0.830 |
Why?
|
| Durapatite | 1 | 2024 | 167 | 0.830 |
Why?
|
| Polyesters | 1 | 2024 | 377 | 0.790 |
Why?
|
| Cosmetic Techniques | 1 | 2024 | 150 | 0.790 |
Why?
|
| Purpura | 1 | 2022 | 117 | 0.760 |
Why?
|
| Anus Diseases | 1 | 2021 | 54 | 0.730 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2022 | 111 | 0.730 |
Why?
|
| Needles | 1 | 2024 | 461 | 0.720 |
Why?
|
| Hyaluronic Acid | 1 | 2024 | 488 | 0.710 |
Why?
|
| Ulcer | 1 | 2021 | 203 | 0.670 |
Why?
|
| Skin Neoplasms | 7 | 2024 | 5864 | 0.660 |
Why?
|
| Psoriasis | 2 | 2022 | 926 | 0.560 |
Why?
|
| Office Visits | 1 | 2021 | 596 | 0.560 |
Why?
|
| Tacrolimus | 1 | 2020 | 750 | 0.540 |
Why?
|
| Biological Products | 2 | 2022 | 947 | 0.510 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2022 | 1376 | 0.470 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 839 | 0.460 |
Why?
|
| Outpatients | 1 | 2021 | 1603 | 0.420 |
Why?
|
| Hamartoma | 2 | 2022 | 236 | 0.320 |
Why?
|
| Melanoma | 2 | 2024 | 5709 | 0.300 |
Why?
|
| Health Care Surveys | 2 | 2021 | 2437 | 0.220 |
Why?
|
| Skin Diseases | 2 | 2022 | 1085 | 0.220 |
Why?
|
| Nevus | 2 | 2022 | 205 | 0.210 |
Why?
|
| Nevus, Sebaceous of Jadassohn | 1 | 2022 | 2 | 0.210 |
Why?
|
| Levamisole | 1 | 2022 | 36 | 0.200 |
Why?
|
| Chilblains | 1 | 2022 | 17 | 0.200 |
Why?
|
| Administration, Cutaneous | 1 | 2024 | 716 | 0.190 |
Why?
|
| Desmin | 1 | 2021 | 99 | 0.190 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2021 | 85 | 0.190 |
Why?
|
| Histamine H1 Antagonists | 1 | 2021 | 101 | 0.180 |
Why?
|
| Thigh | 1 | 2022 | 239 | 0.180 |
Why?
|
| Genetic Fitness | 1 | 2021 | 120 | 0.170 |
Why?
|
| Heart Septal Defects | 1 | 2021 | 191 | 0.170 |
Why?
|
| Ambulatory Care | 2 | 2021 | 2784 | 0.170 |
Why?
|
| Prescriptions | 1 | 2022 | 388 | 0.170 |
Why?
|
| Pancreatic Elastase | 1 | 2019 | 125 | 0.160 |
Why?
|
| Administration, Topical | 1 | 2020 | 704 | 0.150 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2021 | 477 | 0.150 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2021 | 452 | 0.150 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2022 | 565 | 0.140 |
Why?
|
| Abdomen | 1 | 2022 | 1137 | 0.130 |
Why?
|
| Muscle, Smooth | 1 | 2020 | 931 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 1328 | 0.130 |
Why?
|
| Lymphoma, B-Cell | 1 | 2022 | 945 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2021 | 843 | 0.120 |
Why?
|
| United States | 6 | 2022 | 73186 | 0.120 |
Why?
|
| Medicare | 3 | 2022 | 6888 | 0.120 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 1027 | 0.110 |
Why?
|
| Drug Costs | 1 | 2022 | 1198 | 0.110 |
Why?
|
| Maternal Age | 1 | 2016 | 805 | 0.110 |
Why?
|
| Humans | 21 | 2024 | 768970 | 0.110 |
Why?
|
| Islets of Langerhans | 1 | 2019 | 1351 | 0.100 |
Why?
|
| Survival Rate | 2 | 2024 | 12873 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 2238 | 0.100 |
Why?
|
| Actins | 1 | 2020 | 2065 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2911 | 0.090 |
Why?
|
| Skin | 1 | 2024 | 4506 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 2565 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4207 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 223851 | 0.060 |
Why?
|
| Female | 10 | 2024 | 397515 | 0.060 |
Why?
|
| Prognosis | 2 | 2022 | 30046 | 0.060 |
Why?
|
| Insulin | 1 | 2019 | 6610 | 0.060 |
Why?
|
| Incidence | 1 | 2022 | 21547 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3431 | 0.050 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2022 | 34 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 5176 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2974 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81903 | 0.050 |
Why?
|
| Connecticut | 1 | 2022 | 365 | 0.050 |
Why?
|
| Guanylate Cyclase | 1 | 2022 | 206 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18354 | 0.050 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2022 | 165 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2022 | 219 | 0.040 |
Why?
|
| Hypertrichosis | 1 | 2020 | 31 | 0.040 |
Why?
|
| Male | 6 | 2024 | 365203 | 0.040 |
Why?
|
| Zygote | 1 | 2020 | 117 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 386 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 4712 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 18068 | 0.040 |
Why?
|
| Mutation | 2 | 2021 | 30266 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 771 | 0.040 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2022 | 737 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 16053 | 0.030 |
Why?
|
| Middle Aged | 4 | 2024 | 223737 | 0.030 |
Why?
|
| Child | 2 | 2021 | 80960 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2019 | 644 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2021 | 2683 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 2000 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 171786 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2022 | 2916 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 89244 | 0.030 |
Why?
|
| Age of Onset | 1 | 2019 | 3346 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2021 | 2630 | 0.020 |
Why?
|
| Pedigree | 1 | 2019 | 4545 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2592 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9565 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2022 | 42683 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3982 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2022 | 7885 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 13021 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15951 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 82072 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16731 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22296 | 0.010 |
Why?
|
| Exercise | 1 | 2016 | 5954 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 41808 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36556 | 0.010 |
Why?
|
| Animals | 2 | 2021 | 169335 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 60131 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 30265 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74976 | 0.010 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_